HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Allergan PLC said today that it is acquiring the rights to a migraine drug development program from Merck & Co. for an upfront payment of $250 million plus milestone payments and tiered royalties.
Allergan PLC, whose eye drug hub is in Irvine, said today that it will buy Oculeve Inc. for $125 million plus milestone payments.
TECHNOLOGY: Hopes to test Lockheed product by year-end
The Orange County Water District is standing ready to test a new technology under development by Lockheed Martin Corp. that could be a game-changer on water treatment, with the potential to lower costs as municipalities and private businesses search for new ways to secure supplies in drought-stricken California.
Mother Trains Business Experience on Disease That Struck Son
Debra Miller’s son has Duchenne muscular dystrophy.
MightySat Rx Device Unavailable in US
Masimo Corp. ended June on a regulatory roll.
Aliso Viejo-based Cianna Medical Inc. has raised $4 million, according to a U.S. Securities and Exchange Commission filing.
PrimeGen Biotech LLC, a stem cell company, has moved from Irvine to a new facility in Santa Ana.
Irvine-based Sabra Health Care REIT Inc. said today that it bought four nursing homes in Maryland for $234 million.
Fountain Valley-based Hyundai Motor America and its nonprofit, Hope on Wheels, will present a final $2 million installment of a $10 million research grant to Children’s Hospital of Orange County on Thursday.
Fountain Valley-based MemorialCare Health System said today that John Bishop is the new chief executive of its Long Beach Memorial, Miller Children’s & Women’s Hospital Long Beach and Community Hospital Long Beach.
KPC Health, a unit of the Riverside-based KPC Group, said today that it named Suzanne Richards chief executive of healthcare operations.
The Food and Drug Administration Wednesday approved Irvine-based Edwards Lifesciences Corp.’s Sapien 3 less-invasive heart valve.
Allergan Plc will buy Westlake Village, Calif.-based Kythera Biopharmaceuticals Inc. for cash and stock valued at $2.1 billion.
Laguna Hills-based device maker Glaukos Corp. has officially opened its upcoming initial public offering, according to a federal filing.
Shares in Irvine-based NuGene International Inc. fell 39% Thursday to $2.61 and a market capitalization of $103 million after the skincare products development company said yesterday that it had no affiliation with a 28-page mailer touting the stock, but the stock recovered some ground Friday morning.